Ibm Retirement Fund Has Raised By $489,592 Its Johnson & Johnson (JNJ) Position; Incline Global Management Has Raised By $23.03 Million Its Cdk Global (CDK) Stake

April 19, 2018 - By Adrian Erickson

CDK Global, Inc. (NASDAQ:CDK) Logo

Ibm Retirement Fund increased Johnson & Johnson (JNJ) stake by 4.82% reported in 2017Q4 SEC filing. Ibm Retirement Fund acquired 3,221 shares as Johnson & Johnson (JNJ)’s stock declined 9.21%. The Ibm Retirement Fund holds 70,094 shares with $10.70M value, up from 66,873 last quarter. Johnson & Johnson now has $342.63B valuation. The stock decreased 2.16% or $2.82 during the last trading session, reaching $127.72. About 9.38 million shares traded or 14.03% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 19, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Incline Global Management Llc increased Cdk Global Inc (CDK) stake by 47.52% reported in 2017Q4 SEC filing. Incline Global Management Llc acquired 324,358 shares as Cdk Global Inc (CDK)’s stock declined 11.91%. The Incline Global Management Llc holds 1.01M shares with $71.77M value, up from 682,500 last quarter. Cdk Global Inc now has $8.88 billion valuation. The stock increased 0.49% or $0.32 during the last trading session, reaching $65.96. About 525,939 shares traded. CDK Global, Inc. (NASDAQ:CDK) has declined 2.80% since April 19, 2017 and is downtrending. It has underperformed by 14.35% the S&P500.

Among 8 analysts covering CDK Global (NASDAQ:CDK), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. CDK Global had 15 analyst reports since August 14, 2015 according to SRatingsIntel. Morgan Stanley downgraded it to “Underweight” rating and $46 target in Tuesday, January 19 report. The firm earned “Equal-Weight” rating on Friday, February 3 by Morgan Stanley. Barrington Research upgraded the shares of CDK in report on Thursday, February 4 to “Outperform” rating. The company was maintained on Wednesday, January 31 by Wells Fargo. The firm has “Underweight” rating by JP Morgan given on Friday, August 14. The firm earned “Market Perform” rating on Wednesday, January 17 by Barrington Research. The stock has “Outperform” rating by Wells Fargo on Wednesday, June 21. The firm has “Outperform” rating given on Monday, July 10 by Evercore. JP Morgan upgraded the stock to “Neutral” rating in Wednesday, April 6 report. On Wednesday, August 9 the stock rating was maintained by Oppenheimer with “Buy”.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Moreover, Starr Inc has 0.25% invested in Johnson & Johnson (NYSE:JNJ). Barnett has 0.07% invested in Johnson & Johnson (NYSE:JNJ) for 962 shares. Obermeyer Wood Invest Counsel Lllp invested 0.22% of its portfolio in Johnson & Johnson (NYSE:JNJ). Saratoga Research And Mgmt reported 2.48% of its portfolio in Johnson & Johnson (NYSE:JNJ). Truenorth Incorporated holds 0.12% in Johnson & Johnson (NYSE:JNJ) or 1,849 shares. Moreover, Murphy Cap Mngmt Inc has 1.98% invested in Johnson & Johnson (NYSE:JNJ) for 103,588 shares. Diversified Company invested 0.37% in Johnson & Johnson (NYSE:JNJ). 575,107 are held by Oregon Pub Employees Retirement Fund. Vident Advisory Limited Liability stated it has 0.06% of its portfolio in Johnson & Johnson (NYSE:JNJ). Somerville Kurt F holds 4.25% or 147,055 shares. Archford Capital Strategies Ltd Liability owns 1.08% invested in Johnson & Johnson (NYSE:JNJ) for 20,762 shares. National Asset Management reported 1.05% in Johnson & Johnson (NYSE:JNJ). Moreover, Weiss Asset Mgmt Limited Partnership has 1.02% invested in Johnson & Johnson (NYSE:JNJ). Livforsakringsbolaget Skandia Omsesidigt accumulated 158,764 shares. Professional Advisory reported 114,445 shares.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity. Stoffels Paulus had sold 155,342 shares worth $20.17 million on Thursday, February 15.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 95 analyst reports since August 7, 2015 according to SRatingsIntel. As per Tuesday, July 18, the company rating was maintained by Stifel Nicolaus. The stock of Johnson & Johnson (NYSE:JNJ) has “Equal-Weight” rating given on Wednesday, October 18 by Barclays Capital. The stock has “Neutral” rating by Atlantic Securities on Friday, December 18. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Wednesday, October 19 by UBS. Wells Fargo maintained the stock with “Buy” rating in Wednesday, October 18 report. The firm has “Underweight” rating given on Friday, July 21 by Alembic. As per Wednesday, October 18, the company rating was maintained by Leerink Swann. On Tuesday, October 17 the stock rating was maintained by BMO Capital Markets with “Buy”. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Societe Generale on Wednesday, April 6. Piper Jaffray maintained the shares of JNJ in report on Tuesday, July 18 with “Hold” rating.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>